CPRX R&D Expenses
Catalyst Pharmaceuticals Inc · R&D Expenses
CPRX R&D Expenses
Latest reported$11.48Mperiod ending
CPRX TTM R&D Expenses ($0.00 → $11.48M)
TTM R&D Expenses
High-resolution chart · PNG
CPRX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 11,483,000 | |
| 12,709,000 | |
| 14,700,000 | |
| 15,327,000 | |
| 13,954,000 | |
| 12,648,000 | |
| 10,822,000 | |
| 91,200,000 | |
| 92,169,000 | |
| 93,150,000 | |
| 95,271,000 | |
| 19,919,000 | |
| 19,948,000 | |
| 19,789,000 | |
| 20,688,000 | |
| 16,865,000 | |
| 17,332,000 | |
| 16,936,000 | |
| 16,119,028 | |
| 15,381,028 | |
| 15,280,671 | |
| 16,496,671 | |
| 18,630,033 | |
| 19,478,072 | |
| 19,757,793 | |
| 18,842,752 | |
| 20,951,331 | |
| 20,892,661 | |
| 19,968,121 | |
| 19,919,204 | |
| 14,906,869 | |
| 13,073,423 | |
| 11,820,350 | |
| 11,375,237 | |
| 10,791,257 | |
| 10,580,334 | |
| 10,637,480 | |
| 11,369,942 | |
| 12,380,899 | |
| 12,929,570 | |
| 12,998,181 | |
| 11,801,342 | |
| 10,353,972 | |
| 10,197,193 | |
| 9,718,643 | |
| 10,117,774 | |
| 9,801,616 | |
| 9,720,076 | |
| 9,753,156 | |
| 8,096,774 | |
| 6,773,383 | |
| 4,623,868 | |
| 3,024,571 | |
| 2,659,597 | |
| 2,875,145 | |
| 2,834,445 | |
| 3,207,339 | |
| 3,383,965 | |
| 2,992,893 | |
| 2,878,847 | |
| 2,771,147 | |
| 2,306,781 | |
| 2,285,170 | |
| 2,636,077 | |
| 3,214,395 | |
| 5,097,440 | |
| 7,822,242 | |
| 9,422,823 | |
| 9,948,714 | |
| 8,710,441 | |
| 6,160,093 | |
| 4,211,862 | |
| 3,312,498 | |
| 2,990,659 | |
| 2,589,561 | |
| 2,321,680 | |
| 1,535,282 | |
| 772,762 | |
| 451,849 | |
| 216,382 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |